Drawing for Serial No. 79290599

USPTO serial 79290599

Serial No. 79290599

Reviewed by CopyMark Law Group

Reg. 6610112Status 700Renewal
Filing date
Status date
Registration date
Jan 11, 2022
Examiner
CIANCI, RYAN MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79290599?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nazly Aileen Bayramoglu

Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC1540 West Warm Springs Road, Suite 100Henderson, NV 89014UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Technical research in the field of pharmaceutical studies; Research on the subject of pharmaceuticals; Pharmaceutical research services; Research in the field of cosmetics, pharmaceuticals and new products; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Laboratory research services relating to pharmaceuticals; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Development of pharmaceutical preparations and medicines; Scientific research for medical purposes in the area of cancerous diseases; Conducting clinical trials for others [scientific research]; medical research; Chemical, biochemical, biological and bacteriological research and analysis; Research and development services in the field of antibodies; Blood analysis services; Medical laboratory services; Biomedical research services; Testing of chemicals; Computer programming in the medical fieldACTIVE—
045Chaperoning; online social networking services; intellectual property consultancy; Licensing of software for management of intellectual property [legal services]; Licensing of intellectual property rights; Legal administration of licencesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 1, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 24, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jun 23, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Apr 11, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 22, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 11, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 5, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 5, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 4, 2021GPNXNOTIFICATION PROCESSED BY IB—
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 6, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 17, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2021ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2021NREVNOTICE OF REVIVAL - E-MAILED—
Sep 15, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 15, 2021PETGPETITION TO REVIVE-GRANTED—
Sep 15, 2021PROATEAS PETITION TO REVIVE RECEIVED—
May 7, 2021MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 7, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 27, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 14, 2020RFNTREFUSAL PROCESSED BY IB—
Oct 24, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 24, 2020RFRRREFUSAL PROCESSED BY MPU—
Oct 3, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 2, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 1, 2020DOCKASSIGNED TO EXAMINER—
Aug 11, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 5, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 30, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance